Literature DB >> 3443096

The primary structure of human dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme.

A Lamouroux1, A Vigny, N Faucon Biguet, M C Darmon, R Franck, J P Henry, J Mallet.   

Abstract

A full length dopamine-beta-hydroxylase (DBH) cDNA clone was isolated from a human pheochromocytoma lambda gt11 library. Both structural and functional evidence confirms the authenticity of the clone: (i) antibodies selected with fusion proteins generated by positive clones precipitate DBH activity, (ii) the sequence of three internal DBH tryptic peptides are included in the deduced DBH sequence, (iii) the previously reported N-terminal 15 amino acids of bovine DBH exhibits a nearly complete identity with that predicted for human DBH. The polypeptide chain of DBH comprises 578 amino acids corresponding to an unmodified protein of 64 862 daltons and is preceded by a cleaved signal peptide of 25 residues. DBH exists in both membrane-bound and soluble forms. The hydropathy plot reveals no obvious hydrophobic segment, except the signal peptide. S1 mapping analysis indicates no diversity in the 5' and 3' extremities of the DBH mRNA. Taken together with available biochemical data, these observations suggest that the membrane attachment of DBH probably results from a post-translational modification, glypiation being the most likely candidate. Comparative amino acid sequence analysis establishes that DBH shares no homology with the other catecholamine synthesizing enzymes, tyrosine hydroxylase and phenylethanolamine-N-methyl transferase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443096      PMCID: PMC553871          DOI: 10.1002/j.1460-2075.1987.tb02734.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Preparation of pancreatic mRNA: cell-free translation of an insulin-immunoreactive polypeptide.

Authors:  P T Lomedico; G F Saunders
Journal:  Nucleic Acids Res       Date:  1976-02       Impact factor: 16.971

2.  Kinetic studies on soluble and membrane-bound dopamine beta-hydroxylase isolated from storage vesicles of heart and adrenal medulla of different species.

Authors:  O E Brodde; F Arens; K Huvermann; H J Schümann
Journal:  Experientia       Date:  1976-08-15

3.  Properties of membrane-bound dopamine-beta-hydroxylase in chromaffin granules from bovine adrenal medulla.

Authors:  D Aunis; M Bouclier; M Pescheloche; P Mandel
Journal:  J Neurochem       Date:  1977-09       Impact factor: 5.372

4.  Neurally mediated increase in dopamine-beta-hydroxylase activity.

Authors:  P B Molinoff; S Brimijoin; R Weinshilboum; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

5.  3,4-dihydroxyphenylethylamine beta-hydroxylase. Physical properties, copper content, and role of copper in the catalytic acttivity.

Authors:  S Friedman; S Kaufman
Journal:  J Biol Chem       Date:  1965-12       Impact factor: 5.157

6.  NH2-terminal sequence of dopamine beta-hydroxylase from bovine adrenal medulla.

Authors:  T Skotland; T Ljones; T Flatmark; K Sletten
Journal:  Biochem Biophys Res Commun       Date:  1977-02-21       Impact factor: 3.575

7.  Proportional release of norepinephrine and dopamine- -hydroxylase from sympathetic nerves.

Authors:  R M Weinshilboum; N B Thoa; D G Johnson; I J Kopin; J Axelrod
Journal:  Science       Date:  1971-12-24       Impact factor: 47.728

8.  Membranes of the adrenal medulla. Behaviour of insoluble proteins of chromaffin granules on gel electrophoresis.

Authors:  H Winkler; H Hörtnagl; A D Smith
Journal:  Biochem J       Date:  1970-06       Impact factor: 3.857

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Selective induction by nerve growth factor of tyrosine hydroxylase and dopamine- -hydroxylase in the rat superior cervical ganglia.

Authors:  H Thoenen; P U Angeletti; R Levi-Montalcini; R Kettler
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

View more
  27 in total

1.  Autonomic dysfunction: diagnosis guided by therapy.

Authors:  R M Robertson; I Biaggioni; R Mosqueda-Garcia; D Robertson
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

2.  Molecular cloning and sequencing of a cDNA of rat dopa decarboxylase: partial amino acid homologies with other enzymes synthesizing catecholamines.

Authors:  T Tanaka; Y Horio; M Taketoshi; I Imamura; M Ando-Yamamoto; K Kangawa; H Matsuo; M Kuroda; H Wada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Characterization of Drosophila tyramine beta-hydroxylase gene and isolation of mutant flies lacking octopamine.

Authors:  M Monastirioti; C E Linn; K White
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

4.  A BamHI polymorphism at the DBH locus.

Authors:  C J Porter; S P Craig; M Burley; E R Levy; H Hinds; A Williams; I W Craig
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

5.  Two TaqI dimorphic sites at the human beta-hydroxylase locus.

Authors:  T D'Amato; M Leboyer; A Malafosse; D Samolyk; A Lamouroux; C Junien; J Mallet
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

6.  Rapid increase in enzyme and peptide mRNA in sympathetic ganglia after electrical stimulation in humans.

Authors:  M Schalling; P E Stieg; C Lindquist; M Goldstein; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop.

Authors:  A Mayerhofer; G D Smith; M Danilchik; J E Levine; D P Wolf; G A Dissen; S R Ojeda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 8.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

Review 9.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

10.  Production and immunocytochemical application of a highly sensitive and specific monoclonal antibody against rat dopamine-beta-hydroxylase.

Authors:  I E Mazzoni; E Jaffe; A C Cuello
Journal:  Histochemistry       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.